In diabetic nephropathy models, GKT137831 reduced glomerular ROS (measured by dihydroethidium staining), decreased albuminuria by over 50%, and attenuated mesangial expansion—effects that correlated with diminished NOX4 expression in podocytes. This evidence concerns the gene NOX4 and diabetic kidney disease.